Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis
NCT01503749
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Liver Cirrhosis
Interventions
DRUG:
G-colony stimulating factor
OTHER:
Infusion of the mobilized monocyte cells
Sponsor
Seoul National University Hospital